文献速递遗传性与小管间质肾病

靶向常染色体显性多囊肾病的新细胞疾病通路

Targeting new cellular disease pathways in autosomal dominant polycystic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

本文综述了常染色体显性多囊肾病(ADPKD)中经典细胞囊性表型之外的新兴细胞通路,包括代谢改变、自噬、炎症、氧化应激和表观遗传修饰,探讨这些通路与囊泡起始、生长或疾病进展的关联,并讨论开发新治疗选择的可能性。

要点

  • ADPKD经典细胞表型包括增殖、凋亡、液体分泌、细胞外基质和纤毛功能改变。
  • 新近研究提示代谢、自噬、炎症、氧化应激和表观遗传修饰可能参与囊泡起始与进展。
  • 靶向这些新通路可能为ADPKD提供新的治疗选择。

核心结论

  • ADPKD的细胞囊性表型可能更广泛,新通路在囊泡起始、生长或疾病进展中可能起重要作用。

研究设计与样本

  • 本文为综述,回顾ADPKD新兴细胞通路并讨论其与囊性发病机制或疾病不同阶段的联系及新治疗开发选项。

主要发现

  • 经典细胞囊性表型包括增殖、凋亡、液体分泌、细胞外基质和纤毛功能的变化。
  • 新近研究提示代谢改变、自噬、炎症、氧化应激和表观遗传修饰可能在囊泡起始、生长或疾病进展中起重要作用。

临床怎么用

  • 理解ADPKD新细胞通路有助于识别新治疗靶点,为开发新疗法提供方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of end-stage renal failure. Understanding the molecular and cellular pathogenesis of ADPKD could help to identify new targets for treatment. The classic cellular cystic phenotype includes changes in proliferation, apoptosis, fluid secretion, extracellular matrix and cilia function. However, recent research, suggests that the cellular cystic phenotype could be broader and that changes, such as altered metabolism, autophagy, inflammation, oxidative stress and epigenetic modification, could play important roles in the processes of cyst initiation, cyst growth or disease progression. Here we review these newer cellular pathways, describe evidence for their possible links to cystic pathogenesis or different stages of disease and discuss the options for developing novel treatments.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Chang MY, C M Ong A. Targeting new cellular disease pathways in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2018. PMID: 28992279. doi:10.1093/ndt/gfx262

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。